Ecofinity Atomix Ltd
Incorporated in 1993, Ecofinity Atomix Ltd
is engaged in the business of trading goods.[1]
- Market Cap ₹ 55.7 Cr.
- Current Price ₹ 80.0
- High / Low ₹ 84.2 / 34.5
- Stock P/E 16.0
- Book Value ₹ 32.3
- Dividend Yield 0.62 %
- ROCE 20.7 %
- ROE 16.1 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Promoter holding is low: 37.8%
- Company has a low return on equity of 13.8% over last 3 years.
- Earnings include an other income of Rs.2.31 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Products Iron & Steel Products
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.20 | 0.42 | 2.87 | 0.39 | 0.76 | 0.30 | 0.00 | 0.20 | 0.19 | 6.53 | 31.07 | 35.12 | 50.02 | |
| Sales growth | -44.44% | +110.00% | +583.33% | -86.41% | +94.87% | -60.53% | -100.00% | -5.00% | +3,336.84% | +375.80% | +13.04% | +38.37% | |
| 0.13 | 0.44 | 2.92 | 0.46 | 0.77 | 0.42 | 0.15 | 0.27 | 0.52 | 6.47 | 29.81 | 32.67 | 47.45 | |
| Operating Profit | 0.07 | -0.02 | -0.05 | -0.07 | -0.01 | -0.12 | -0.15 | -0.07 | -0.33 | 0.06 | 1.26 | 2.45 | 2.57 |
| OPM % | 35.00% | -4.76% | -1.74% | -17.95% | -1.32% | -40.00% | 66.67% | -35.00% | -173.68% | 0.92% | 4.06% | 6.98% | 5.14% |
| 0.00 | -0.02 | 0.30 | 0.10 | 0.24 | 0.13 | 0.03 | 0.07 | 0.07 | 0.22 | 0.69 | 2.12 | 2.31 | |
| Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.13 | 0.34 |
| Depreciation | 0.08 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.02 | -0.08 | 0.25 | 0.03 | 0.23 | 0.01 | -0.12 | 0.00 | -0.26 | 0.28 | 1.94 | 4.44 | 4.54 |
| Tax % | 50.00% | 0.00% | 8.00% | 33.33% | 30.43% | 0.00% | 0.00% | 0.00% | 3.57% | 21.13% | 23.87% | ||
| -0.03 | -0.08 | 0.23 | 0.02 | 0.15 | 0.01 | -0.13 | 0.00 | -0.26 | 0.27 | 1.52 | 3.37 | 3.48 | |
| EPS in Rs | -0.08 | -0.21 | 0.60 | 0.05 | 0.39 | 0.03 | -0.34 | 0.00 | -0.68 | 0.70 | 2.18 | 4.84 | 5.00 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.89% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | % |
| 3 Years: | 470% |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 93% |
| 3 Years: | 142% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 34% |
| 3 Years: | 36% |
| 1 Year: | 101% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | 14% |
| Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 6.96 | 6.96 | 6.96 |
| Reserves | -0.77 | -0.85 | -0.62 | -0.60 | -0.45 | -0.44 | -0.57 | -0.57 | -0.83 | -0.56 | 11.31 | 14.34 | 15.56 |
| 0.00 | 0.05 | 0.08 | 0.18 | 0.55 | 0.37 | 0.42 | 0.42 | 0.02 | 0.00 | 0.01 | 3.09 | 4.50 | |
| 1.11 | 0.09 | 0.91 | 1.06 | 0.65 | 0.83 | 0.17 | 0.12 | 0.00 | 2.42 | 0.31 | 2.98 | 0.83 | |
| Total Liabilities | 4.19 | 3.14 | 4.22 | 4.49 | 4.60 | 4.61 | 3.87 | 3.82 | 3.04 | 5.71 | 18.59 | 27.37 | 27.85 |
| 1.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 1.33 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Investments | 0.00 | 0.31 | 0.31 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.42 | 8.73 | 8.90 |
| 2.38 | 2.83 | 3.91 | 4.28 | 4.60 | 4.61 | 3.87 | 3.82 | 3.04 | 5.71 | 12.17 | 18.62 | 17.62 | |
| Total Assets | 4.19 | 3.14 | 4.22 | 4.49 | 4.60 | 4.61 | 3.87 | 3.82 | 3.04 | 5.71 | 18.59 | 27.37 | 27.85 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | -0.58 | -2.03 | -0.31 | -0.38 | -0.08 | -0.12 | -0.02 | 0.30 | 0.14 | -7.31 | -2.12 | |
| 0.00 | 1.42 | 1.53 | 0.33 | 0.12 | 0.13 | 0.02 | 0.00 | 0.06 | 0.20 | -6.24 | -0.36 | |
| -0.01 | -0.35 | 0.02 | 0.10 | 0.37 | -0.19 | 0.05 | 0.00 | -0.40 | -0.02 | 13.46 | 2.70 | |
| Net Cash Flow | 0.01 | 0.48 | -0.47 | 0.12 | 0.11 | -0.13 | -0.05 | -0.01 | -0.04 | 0.31 | -0.09 | 0.21 |
| Free Cash Flow | 0.02 | 1.14 | -2.03 | -0.31 | -0.38 | -0.08 | -0.12 | -0.02 | 0.30 | 0.14 | -7.31 | -2.14 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 43% | 2,900% | 4,060% | 443% | 3,100% | 67% | 80% | 29% | -91% | 250% | -556% | -43% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1,003.75 | 451.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 117.38 | 91.04 | 134.38 | |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.54 | 0.00 | 0.00 | ||||
| Days Payable | 136.80 | |||||||||||
| Cash Conversion Cycle | 1,003.75 | 451.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.12 | 91.04 | 134.38 | |
| Working Capital Days | -273.75 | 373.69 | 331.93 | 2,339.74 | 1,488.82 | 3,966.33 | 4,635.50 | 4,552.89 | 164.89 | 136.27 | 125.23 | |
| ROCE % | -0.33% | -1.31% | 7.86% | 0.89% | 6.23% | 0.26% | -3.21% | 0.00% | -7.72% | 8.85% | 15.58% | 20.72% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Subsidiaries / Joint Ventures count |
|
||||||||||
| Number of Permanent Employees count |
|||||||||||
| Subsidiary Turnover Rs. Lakhs |
|||||||||||
| Equity Shares Issued via Preferential Allotment shares |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- Results- Financials Results For 30Th September 2026
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th November, 2026
- Board approved Q2 FY2026-27 standalone and consolidated unaudited results on 7 November 2026.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Shareholder Meeting / Postal Ballot-Outcome of EGM
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 03Rd November, 2026
- Corrigendum to EGM notice excludes one allottee and reduces preferential warrant issue to 15,52,100.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
Business Overview:[1]
EAL (Formerly known as Aryavan Enterprise
Limited) is Trader - Wholesaler /Distributor with a 60% Stake in Bulk Drug Intermediate Partnership Firm.